Indian pharmaceutical giant warns of revenue loss, litigation after ransomware attack

The largest pharmaceutical company in India confirmed a ransomware attack in its regulatory filings this week, explaining that the incident involved the theft of company data and personal information. Sun Pharmaceuticals – the fourth-largest specialty generic pharmaceutical company in the world – said in filings with the Bombay Stock Exchange that efforts to contain and

attack briefs cybercrime data exchange incident india information litigation loss personal personal information pharmaceuticals ransomware ransomware attack regulatory revenue stock stock exchange theft world